Movano (NASDAQ:MOVE) Downgraded by Wall Street Zen to “Sell”

Wall Street Zen cut shares of Movano (NASDAQ:MOVE) from a hold rating to a sell rating in a research report report published on Saturday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Movano Stock Up 1.8%

Shares of NASDAQ:MOVE opened at $7.16 on Friday. The company has a market capitalization of $5.98 million, a P/E ratio of -0.66 and a beta of 0.79. Movano has a 52-week low of $4.67 and a 52-week high of $58.76. The stock’s fifty day simple moving average is $8.97 and its 200-day simple moving average is $7.57.

Movano (NASDAQ:MOVE) last announced its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share for the quarter, beating the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to the consensus estimate of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Insiders Place Their Bets

In related news, CTO Michael Aaron Leabman sold 6,845 shares of the stock in a transaction on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the transaction, the chief technology officer directly owned 22,639 shares of the company’s stock, valued at approximately $150,775.74. This trade represents a 23.22% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jeremy Cogan sold 8,218 shares of Movano stock in a transaction on Tuesday, January 6th. The shares were sold at an average price of $7.79, for a total value of $64,018.22. Following the completion of the transaction, the chief financial officer owned 15,107 shares in the company, valued at $117,683.53. The trade was a 35.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 32,578 shares of company stock worth $239,964. 10.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new position in shares of Movano Inc. (NASDAQ:MOVE) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent filing with the SEC. Institutional investors own 16.64% of the company’s stock.

Trending Headlines about Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional interest: Citadel Advisors disclosed a new, small stake in Movano (49,262 shares), which signals some institutional conviction and provides modest demand support for the thinly traded name. MarketBeat MOV E profile
• Positive Sentiment: Falling short interest: short interest declined in late December (helping reduce one technical headwind and lowering one source of immediate downside pressure). MarketBeat short interest
• Neutral Sentiment: Broader market/geopolitical weakness: wider market pullbacks and geopolitical headlines are hitting small-cap and tech names harder today, likely amplifying Movano’s move. This is a market-driven headwind rather than company-specific news. RTT News: Market Move
• Negative Sentiment: Clustered insider selling: CTO Michael Leabman sold multiple tranches this month (e.g., 6,845 shares on Jan. 14 at ~$6.66; additional sales Jan. 12–13). Large, concentrated insider sales in a tiny, low‑float stock weigh heavily on sentiment and can trigger further price pressure. SEC filing (Leabman)
• Negative Sentiment: Additional insider sales: CFO Jeremy Cogan also disclosed recent sales (including 8,218 shares on Jan. 6), further reducing insider ownership and reinforcing negative market perception. SEC filing (Cogan)
• Negative Sentiment: Weak fundamentals and tiny scale: the recent quarter showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M versus the street estimate). For a micro‑cap with a market cap in the single‑digit millions and low liquidity, execution risk and potential dilution remain real concerns. Earnings summary
• Negative Sentiment: Analyst/structural headwinds: small market cap, thin volume, and a consensus skewed toward “Sell” make sustained rebounds difficult absent clear operational progress or meaningful new revenue evidence. Company profile & ratings

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.